Werewolf Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Werewolf Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q2 2024.
  • Werewolf Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $6.35M, a 18.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $6.35M -$1.44M -18.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $6.51M -$1.62M -19.9% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $6.89M -$1.58M -18.6% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $7.25M -$1.35M -15.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $7.79M -$1.28M -14.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $8.13M -$3.08M -27.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $8.46M -$4.95M -36.9% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $8.6M +$6.64M +338% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $9.07M +$6.94M +325% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $11.2M +$8.9M +386% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $13.4M +$10.9M +443% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $1.96M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $2.14M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $2.31M Mar 31, 2021 10-Q 2021-06-10
Q4 2020 $2.47M Dec 31, 2020 10-K 2022-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.